FDMT vs TXN · rev $37.0K vs P/E 52, rev $17.68B
4D Molecular Therapeutics Inc (FDMT) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported TXN revenue for 2025-12-31 was $17.68B. Net income was $5.00B. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
FDMT currently screens at market cap $518.1M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the FDMT and TXN stock pages for the full models.
Not investment advice.